Monographie - Tirofiban - Stabilis 4.0

Ultimele actualizari :
08/05/2024

Anticoagulant

Tirofiban

Injectabil

Stabilitatea in solutie

Stabilitatea in amestec

Factorii care influenteaza stabilitatea

Compatibilitate

Microunde

Bibliografie

Pdf

Denumirea comerciala

Denumirea comerciala

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Aggrastat	Arabia Saudita, Australia, Austria, Belgia, Canada, Danemarca, Elvetia, Emiratele Arabe Unite, Finlanda, Germania, Iran, Irlanda, Italia, Luxemburg, Malaezia, Marea Britanie, Norvegia, Noua Zeelandă, Olanda, Polonia, Portugalia, SUA, Suedia, Turcia, Ungaria
Agrastat	Argentina, Brazilia, Chilli, Columbia, Ecuador, Egipt, Franta, Maroc, Mexic, Peru, Spania, Venezuela
Thrombostat	Turcia
Tirofiban	Germania, Spania
Tiroprest	Turcia
Welban	Spania
Xtraban	India

Bibliografie

Injectabil

Bibliografie : Tirofiban

	Tip	Publicare
1071	Ziar	Bergquist PA, Zimmermann J, Kenney RR, Han RYH, Hunke WA. Stability of tirofiban hydrochloride in three commonly used IV solutions and polyvinyl chloride administration sets. Am J Health-Syst Pharm 1999 ; 56: 1627-1629.
1420	Ziar	Bergquist PA, Hunke WA, Reed RA, Manas D, Forsyth RJ, Kenney RR, Cook J, Holahan M. Compatibility of tirofiban HCl with dopamine HCl, famotidine, sodium heparin, lidocaine HCl and potassium chloride during simulated Y-site administration. J Clin Pharm Ther 1999 ; 24: 125-132.
1508	Ziar	Voirol P, Berger-Gryllaki M, Pannatier A, Eggimann P, Sadeghipour F. Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU. EJHP 2015 ;22:123-124.
1512	Laborator	Tirofiban (Aggrastat®) - Summary of Product Characteristics Beacon Pharmaceuticals Ltd 2015
1600	Ziar	Garabito MJ, Jimenez L, Bautista J, Santos-Rubio MD, Perez Rodrigo I. Stability of tirofiban hydrochloride in 0.9% sodium chloride injection for 30 days. Am J Health-Syst Pharm 2001 ; 58: 1850-1851.
1603	Ziar	Bergquist PA, Manas D, Hunke WA, Reed RA. Stability and compatibility of tirofiban hydrochloride during simulated Y-site administration with other drugs. Am J Health-Syst Pharm 2001 ; 58: 1218-1223.
1611	Ziar	Chalmers JR, Bobek MB, Militello MA. Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs. Am J Health-Syst Pharm 2001 ; 58: 504-506.
1713	Ziar	Trissel LA, Saenz CA. Compatibility screening of bivalirudin during simulated Y-site administration with other drugs. Int J Pharm Compound 2002 ; 6: 311-315.
2004	Ziar	Patel K, Hursting MJ. Compatibility of argatroban with abciximab, eptifibatide, or tirofiban during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 1381-1384.
3823	Ziar	Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R. Compatibilité physique de médicaments administrés dans l’unité de soins intensifs Pharmactuel 2015 ; 48, 3 : 146-152.

Mentions Légales